170. Occipital horn syndrome Clinical trials / Disease details


Clinical trials : 2 Drugs : 4 - (DrugBank : 3) / Drug target genes : 9 - Drug target pathways : 14

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04977388
(ClinicalTrials.gov)
July 12, 20219/7/2021NORTHERA (DROXIDOPA) for Dysautonomia in Adult Survivors of Menkes Disease and Occipital Horn SyndromePhase I/II Study of NORTHERA (DROXIDOPA) for Dysautonomia in Adult Survivors of Menkes Disease and Adults With Occipital Horn Syndrome: Double-blind Placebo-controlled Randomized Crossover Clinical TrialMenkes Disease;Occipital Horn SyndromeDrug: Droxidopa;Other: PlaceboStephen G. Kaler, MDNULLRecruiting18 Years50 YearsAll6Phase 1/Phase 2United States